Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCW7N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,307
Award facts
- Contract value 100% obligated
- $7,306.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,306.56 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in respiratory therapy. The contract, awarded on December 29, 2025, with an ultimate completion date of December 30, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026.
As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency's Medical Supply Chain. The SPE2DX indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency worldwide. AmerisourceBergen's federal contract history demonstrates consistent capability in fulfilling diverse medical procurement requirements across multiple therapeutic domains with firm fixed pricing structures.
Quick answers
Who was awarded contract SPE2DR26FCW7N?
SPE2DR26FCW7N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FCW7N worth?
The government has obligated $7,307 on SPE2DR26FCW7N.
Is contract SPE2DR26FCW7N an order under another contract?
Yes. SPE2DR26FCW7N is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCW7N competed?
The extent of competition for SPE2DR26FCW7N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award